Detalhe da pesquisa
1.
Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Blood
; 139(5): 732-747, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653238
2.
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Blood
; 135(21): 1859-1869, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267500
3.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Eur J Haematol
; 106(4): 493-499, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378569
4.
Richter Syndrome.
Curr Oncol Rep
; 23(3): 26, 2021 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580422
5.
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Blood
; 131(22): 2413-2425, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29449275
6.
Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance.
J Natl Compr Canc Netw
; 19(2): 227-233, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33383567
7.
The future of cell-free DNA testing to guide therapeutic decisions in B-cell lymphomas.
Curr Opin Hematol
; 26(4): 281-287, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31082825
8.
Mechanisms of resistance to venetoclax.
Blood
; 140(20): 2094-2096, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394906
9.
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.
Am J Hematol
; 98(7): E157-E160, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067157
10.
Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma.
Curr Oncol Rep
; 20(10): 79, 2018 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132080
11.
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib.
Hematol Oncol
; 40(5): 1105-1108, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35656838
12.
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.
Hematol Oncol
; 40(5): 1100-1104, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613703
13.
Treatment of Richter's Syndrome.
Curr Treat Options Oncol
; 18(12): 75, 2017 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29159711
14.
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials.
Am J Hematol
; 96(8): E269-E272, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878220
15.
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.
Am J Hematol
; 96(8): E306-E310, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989438
16.
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study.
Am J Hematol
; 96(5): E168-E171, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580969
17.
Impact of smoking on lung cancer treatment effectiveness: a review.
Future Oncol
; 12(18): 2149-61, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27424719
18.
Age-related clonal hematopoiesis and monoclonal B-cell lymphocytosis/chronic lymphocytic leukemia: a new association?
Haematologica
; 103(5): 751-752, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29712819
19.
SOHO State of the Art Updates and Next Questions | Treatment of Richter's Transformation.
Clin Lymphoma Myeloma Leuk
; 23(11): 786-799, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586917
20.
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis.
Amyloid
; 30(4): 416-423, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37431662